Tibsovo Interactions
There are 579 drugs known to interact with Tibsovo (ivosidenib), along with 2 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 247 are major, 315 are moderate, and 17 are minor.
- View all 579 medications that may interact with Tibsovo
- View Tibsovo alcohol/food interactions (2)
- View Tibsovo disease interactions (2)
Most frequently checked interactions
View interaction reports for Tibsovo (ivosidenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- Alimta (pemetrexed)
- amitriptyline
- Aubagio (teriflunomide)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- clonazepam
- clonidine
- Cosentyx (secukinumab)
- Crestor (rosuvastatin)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- Humira (adalimumab)
- Kalydeco (ivacaftor)
- losartan
- Lyrica (pregabalin)
- magnesium oxide
- Ozempic (semaglutide)
- Retrovir (zidovudine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tegretol (carbamazepine)
Tibsovo alcohol/food interactions
There are 2 alcohol/food interactions with Tibsovo (ivosidenib).
Tibsovo disease interactions
There are 2 disease interactions with Tibsovo (ivosidenib) which include:
Report options
QR code containing a link to this page
More about Tibsovo (ivosidenib)
- Tibsovo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
